Ethyl violet G
CAS: 65121-93-9
Ref. 3D-FE166421
| 1kg | To inquire | ||
| 50g | To inquire | ||
| 100g | To inquire | ||
| 250g | To inquire | ||
| 500g | To inquire |
Product Information
- Ethanaminium, N-(4-(bis(4-(diethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-ethyl-, (T-4)-tetrachlorozincate(2-) (2:1)
- Zincate(2-), tetrachloro-, (T-4)-, bis[N-[4-[bis[4-(diethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethylethanaminium]
- (4-(Bis(4-(diethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)diethylammonium tetrachlorozincate
Ethyl violet G is a pyrazole derivative that binds to matrix metalloproteinases and inhibits their activity. Ethyl violet G has been shown to inhibit the growth of cancer cells by blocking the production of insulin-like growth factor (IGF) and other growth factors. The binding of ethyl violet G to matrix metalloproteinases reduces the degradation rate of collagen, leading to an increase in tumor size. This drug also inhibits the expression of estrogen receptors and progesterone receptors, which are responsible for regulating cell division in breast tissue. Ethyl violet G can be used to enhance ultrasound imaging during breast cancer surgery by increasing the viscosity of blood vessels in the area. This drug has not been evaluated in pregnant women or children.
Chemical properties
Technical inquiry about: 3D-FE166421 Ethyl violet G
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
